Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →Impact factor of Drug Design, Development and Therapy (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Drug Design, Development and Therapy published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Q1Pharmacology & Pharmacyrank 72 of 371 journals
- Q2Chemistry, Medicinalrank 22 of 74 journals
Quartiles here rank journals of the same Web of Science category by 2-year citedness; they are not the official JCR quartiles.
Citations and papers per year
Open access (listed in DOAJ); article processing charge listed at about US$2,836.
Indexing of Drug Design, Development and Therapy
- ISSN
- 1177-8881
- Publisher
- Dove Medical Press Ltd
- Country
- England
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Chemistry, Medicinal, Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
What Drug Design, Development and Therapy publishes: real papers
Papers by ScholarsColab mentors in Drug Design, Development and Therapy
- Glycyrrhetinic acid and E. resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson’s disease: a pharmacoinformatics study201444 citations
Mirza Ahmed Hammad - Structural dynamics and inhibitor searching for Wnt-4 protein using comparative computational studies201513 citationsMirza Ahmed Hammad
Reviewer comments and rejection reasons for Drug Design, Development and Therapy
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Planning to submit here? A Manuscript Audit by a PhD reviewer in your area checks your paper for the issues reviewers raise most often.
Get a Manuscript Audit →Preparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
Journals similar to Drug Design, Development and Therapy
Journals where our mentors published the closest work to the papers above:
- Medicinal Plants and Aromatics: A Holistic Health PerspectiveNot found in our indexing lists2 mentor papers
- Frontiers in EndocrinologySCIEScopusJCR 20245 mentor papers
- Plant derived bioactive compounds in human health and diseaseNot found in our indexing lists1 mentor paper
- Journal of Molecular StructureSCIEScopusJCR 202447 mentor papers
- Central Nervous System Agents in Medicinal Chemistry (Formerly Current Not found in our indexing lists1 mentor paper
- Food and Chemical ToxicologySCIEScopusJCR 20249 mentor papers
Find the right journal for your paper
Is Drug Design, Development and Therapy right for your paper? Compare journals
Paste your title, keywords or abstract. We match it against 28,582 journal papers published by PhD researchers on ScholarsColab and show where the closest work appeared, with each journal’s indexing (SCIE, SSCI, AHCI, ESCI, Scopus, JCR 2024).
How it works: no AI or language model is used. Your words are matched against the titles of real published papers by our mentors; journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; “not found in our indexing lists” does not prove a journal is unindexed. Always check a journal’s scope and current indexing before submitting.
Frequently asked questions
What is the impact factor of Drug Design, Development and Therapy?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Drug Design, Development and Therapy is 4.63: papers it published in the two previous years were cited 4.63 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Drug Design, Development and Therapy?
The h-index of Drug Design, Development and Therapy is 132 (OpenAlex, October 2026): 132 of its papers have each been cited at least 132 times. Its i10-index is 3,422.
What is the APC of Drug Design, Development and Therapy?
OpenAlex lists an article processing charge (APC) of about US$2,836 for Drug Design, Development and Therapy, an open access journal (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
Is Drug Design, Development and Therapy a Q1 journal?
By 2-year citedness, Drug Design, Development and Therapy ranks 72 of 371 journals in Pharmacology & Pharmacy, which places it in Q1 of that Web of Science category. This ranking is calculated by ScholarsColab from OpenAlex data; the official JCR quartile can differ.
Is Drug Design, Development and Therapy indexed in Scopus?
Yes. Drug Design, Development and Therapy appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Drug Design, Development and Therapy an SCIE journal?
Yes. Drug Design, Development and Therapy is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Drug Design, Development and Therapy in Journal Citation Reports (JCR)?
Yes. Drug Design, Development and Therapy is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Have ScholarsColab mentors published in Drug Design, Development and Therapy?
Yes. 2 papers by 1 mentor was published in Drug Design, Development and Therapy between 2014 and 2015, with 57 citations in total.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.